| |
|
|
|
Hyatt Regency Washington on Capitol Hill, Washington, DC
August 20-22, 2013
August 20-21: - Enabling Point-of-Care Diagnostics
- Cancer Molecular Markers to Guide Therapy
- Companion Diagnostics: From Biomarker Validation to Regulatory Approval
August 21-22: - Molecular Diagnostics for Infectious Disease
- Molecular Profiling for Circulating Tumor Cells
- Companion Diagnostics: Advancing Technologies and Winning Reimbursement
- Commercialization of Molecular Diagnostics
Visit http://bit.ly/10W1R5u for more information.
|
|
|
|
|
|
|
|
Organized by:
|
|
Cambridge Healthtech Institute |
|
|
Invited Speakers:
|
|
Speakers include: - Chong H. Ahn, Ph.D., Mitchell P. Kartalia Chair and Professor, Microsystems and BioMEMS Laboratory, School of Electronics and Computing Systems, University of Cincinnati
- Randy Allen, Ph.D., Manager, Corporate Relations, Clinton Health Access Initiative (CHAI)
- Andrew J. Armstrong, M.D., Associate Professor, Medicine and Surgery, Duke Cancer Institute, Divisions of Medical Oncology and Urology, Duke University
- J. Carl Barrett, Ph.D., Vice President, Translational Sciences Onc iMed, AstraZeneca
- Keith F. Batchelder, M.D., CEO, Genomic Healthcare Strategies
- John F. Beeler, Ph.D., Director, Theranostics & Business Development, bioMerieux
- Chiara Bell, Founder and CEO, CareTicker
- Kenneth J. Bloom, M.D., CMO, Clarient, Inc.
- Aaron D. Bossler, M.D., Ph.D., Clinical Associate Professor, Director Molecular Pathology Laboratory and Molecular Genetic Pathology Fellowship Program, University of Iowa Hospitals and Clinics and Co-Chair, AMP Economic Affairs Committee
- Roslyn A. Brandon, Ph.D., Co-Founder, President & CEO Immunexpress
- Jeremy Bridge-Cook, Ph.D., Senior Vice President, Research & Development, Luminex
- John P. Burke, M.D., Chief, Division of Clinical Epidemiology & Infectious Diseases, Intermountain Medical Center and LDS Hospital, & Professor of Internal Medicine at the University of Utah
- Mitchell I. Burken, M.D., Medicare Medical Director, Novitas Solutions, Inc.
- Scott Cameron, M.D., Ph.D., Oncology Director, Clinical Research Physician, Novartis Institutes for BioMedical Research, Inc.
- Karen C. Carroll, M.D., Professor of Pathology and Medicine; Director, Division of Medical Microbiology, The Johns Hopkins University School of Medicine
- Jeffrey Chalmers, Ph.D., Professor, Chemical and Biomolecular Engineering, Ohio State University
Visit NextGenerationDx.com/ADX/Speakers to see a full speaker list.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
July 19, 2013
|
|
|
|
|
|
|
|
Registration:
|
|
Register Now
|
|
|
E-mail:
|
|
kwaterman@healthtech.com
|
|
|
|
|
|
|
|
|